- Health Spotlight's Systemic Lupus Erythematosus Insights
- Posts
- Weekly Spotlight - 27.11.24
Weekly Spotlight - 27.11.24
New Treatment Strategies Aim to Reduce Corticosteroid Use in SLE Patients
Community |
Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters! |
Latest News |
New Treatment Strategies Aim to Reduce Corticosteroid Use in SLE Patients |
Researchers discuss strategies to improve disease management and reduce corticosteroid use in patients with systemic lupus erythematosus (SLE), highlighting the importance of personalized treatment plans and the potential benefits of alternative therapies to minimize side effects and enhance patient outcomes. |
GLP-1 RA Drugs Show Promise in Managing Lupus Nephritis Symptoms in Patients |
Research suggests that GLP-1 receptor agonists, a class of drugs typically used for diabetes, may also benefit people with systemic lupus erythematosus (SLE) who have lupus nephritis. These drugs could potentially reduce inflammation and improve kidney function in SLE patients. |
New ACR Guidelines for Lupus Nephritis Treatment in 2024: Key Updates and Recommendations |
The American College of Rheumatology (ACR) has released new guidelines for managing lupus nephritis, a common complication of systemic lupus erythematosus that affects the kidneys. The guidelines outline updated treatment strategies, including the use of immunosuppressive medications and biologics to improve patient outcomes. |
Anifrolumab Shows Promise in Reducing Organ Damage in SLE Patients Compared to Standard Care |
Anifrolumab, a new medication, has shown to be more effective in preventing organ damage in patients with systemic lupus erythematosus (SLE) compared to the current standard of care. It targets the type I interferon pathway, which is often overactive in SLE, leading to better outcomes for patients. |
Air Pollution Linked to Higher Risk of Lupus, New Study Finds |
Chronic exposure to air pollutants may increase the risk of developing systemic lupus erythematosus, according to new research. The study suggests that long-term inhalation of pollutants like particulate matter and nitrogen dioxide could contribute to the onset of the disease. This finding highlights the importance of air quality in health. |
Health Spotlight’s Systemic Lupus Erythematosus is a Contentive publication in the Healthcare division